Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TBPH | SPRY | ESPR | ||
| Company | Theravance Bio Ord | Ars Pharmaceuticals Inc | Esperion Theraptc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.38 | 9.84 | 3.78 | ||
| High | 18.80 | 10.99 | 4.04 | ||
| Low | 18.02 | 9.80 | 3.78 | ||
| Latest | 18.79 | 10.49 | 3.93 | ||
| Change | +0.61 | +0.67 | +0.13 | ||
| % Change | +3.36% | +6.82% | +3.42% | ||
| Volume | 1,241,800 | 2,867,200 | 12,480,601 | ||
| 20-Day Average Volume | 588,530 | 1,986,305 | 6,757,290 | ||
| Previous Close | 18.18 | 9.82 | 3.80 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.50 | 9.77 | 3.75 | ||
| 20-Day Raw Stochastic | 50.00% | 79.96% | 83.05% | ||
| 20-Day Relative Strength | 59.42 | 55.35 | 60.67 | ||
| Weighted Alpha | +110.13 | -19.59 | +68.50 | ||
| Today's Opinion | 100% Buy | 40% Sell | 100% Buy | ||
| Previous Opinion | 88% Buy | 40% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.41% since 12/12/25 | +2.44% since 12/12/25 | +2.08% since 12/12/25 | ||
| Low | 17.25 on 12/17/25 | 9.78 on 12/18/25 | 3.63 on 12/17/25 | ||
| High | 18.80 on 12/19/25 | 10.99 on 12/19/25 | 4.04 on 12/19/25 | ||
| 1-Month | |||||
| %Chg | +5.98% since 11/19/25 | +47.95% since 11/19/25 | +40.86% since 11/19/25 | ||
| Low | 17.25 on 12/17/25 | 6.66 on 11/21/25 | 2.82 on 11/20/25 | ||
| High | 20.33 on 11/28/25 | 11.45 on 12/11/25 | 4.13 on 12/12/25 | ||
| 3-Month | |||||
| %Chg | +35.37% since 09/19/25 | +7.15% since 09/19/25 | +47.74% since 09/19/25 | ||
| Low | 13.50 on 10/15/25 | 6.66 on 11/21/25 | 2.30 on 10/08/25 | ||
| High | 20.33 on 11/28/25 | 11.70 on 10/10/25 | 4.13 on 12/12/25 | ||
| 6-Month | |||||
| %Chg | +76.93% since 06/18/25 | -34.07% since 06/18/25 | +257.27% since 06/18/25 | ||
| Low | 10.44 on 06/23/25 | 6.66 on 11/21/25 | 0.95 on 07/01/25 | ||
| High | 20.33 on 11/28/25 | 18.90 on 06/27/25 | 4.13 on 12/12/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 921,217 | 970,697 | 908,439 | ||
| Shares Outstanding, K | 50,672 | 98,849 | 239,063 | ||
| Annual Sales | 64,380,000 | 89,150,000 | 332,310,000 | ||
| Annual Net Income | -56,420,000 | 8,000,000 | -51,750,000 | ||
| Last Quarter Sales | 19,990,000 | 32,500,000 | 87,310,000 | ||
| Last Quarter Net Income | 3,620,000 | -51,150,000 | -31,330,000 | ||
| 60-Month Beta | 0.14 | 0.82 | 1.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.04 on 11/10/25 | -0.52 on 11/10/25 | -0.16 on 11/06/25 | ||
| Latest Earnings Date | 02/25/26 | 03/19/26 | 03/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 38.11 | 0.00 | 0.00 | ||